MO

Meghmani Organics Ltd

Q1 FY26Fertilizers & Agrochemicals

Meghmani Organics Q1 FY26 earnings call: Revenue & Margins

Q1 FY26 earnings call: what management guided on revenue, margins and order book.

Price₹60
Market cap₹1.6K Cr
P/E25.0
Updated23 Aug 2026
Read4 min read

The short version

Meghmani Organics anticipates double-digit growth in the crop protection segment for the next 2-3 years. Meghmani Organics targets double-digit revenue growth, aiming for 15%-20% top-line growth over the next few years, particularly in crop protection.

From Meghmani Organics Ltd's Q1 FY26 earnings-call transcript · updated 23 Aug 2026.

Revenue & Sales Performance

  • Meghmani Organics anticipates double-digit growth in the crop protection segment for the next 2-3 years.
  • For FY '26, the company aims for 15-20% growth in top-line, although maintaining a consistent 20% growth may be challenging as base grows.
  • Growth drivers include a shift towards high-value, new generation products manufactured in the multipurpose plant.
  • Expansion into new geographies and increased registrations in various markets are expected to fuel growth.
  • Utilization in crop protection plants is currently around 76-77%; growth will be driven by higher-value products and increased conversion into formulations.
  • Nano Urea product segment expects double-digit growth.

2 more points from Meghmani Organics Ltd's call on revenue

Pro opens every point from 15K+ earnings calls

Profitability & Margins

See what Meghmani Organics Ltd said on profitability & margins — free account, 30 seconds.

Capital Expenditure Plans

  • Meghmani Organics has completed recent capex with no new capex capitalized in the latest quarter; depreciation remains stable as a result.
  • No further capex planned currently; depreciation expected to remain at the current level going forward.
  • Focus is on better utilization of existing multipurpose plant (MPP) capacity, which is at ~76%-77% utilization.
  • Growth is driven by high-value new-generation products manufactured in the multipurpose plant, enabling revenue growth without major capex.
  • Plans exist to ramp up titanium dioxide plant capacity and improve realization; detailed updates expected by Q3.

2 more points from Meghmani Organics Ltd's call on capex

Pro opens every point from 15K+ earnings calls

Top-ranked in Fertilizers & Agrochemicals

Ranked on what management guided this quarter

Guidance-ranked
Rev 3Mar 3
3
Rev 3Mar 3
4
Rev 3Mar 3
5
Rev 3Mar 3
Sign up free to see 3 moreTakes 30 seconds · no cardSign up

Rank buckets describe management commentary on revenue and margin. Not investment advice, and not a forecast of returns.

Fundraising & Capital Structure

See what Meghmani Organics Ltd said on fundraising & capital structure — free account, 30 seconds.

Order Book & Pipeline

The transcript and pages provided from Meghmani Organics Limited's document do not contain specific details about the current or expected order book or pending orders. While the discussion covers various topics including growth, raw material costs, registrations, market potential (especially Brazil), and pricing trends, there is no direct mention or disclosure of order book size, order backlog, or pending orders. Key points related to demand and outlook: - The company expects double-digit growth in the crop protection segment over the next 2-3 years. - They have more than 40 registrations in Brazil, with 6 approved and 30-35 in pipeline, indicating progressive market expansion.

2 more points from Meghmani Organics Ltd's call on order book

Pro opens every point from 15K+ earnings calls

Meghmani Organics Ltd — Quarterly revenue & net profit

Revenue Net profit Net loss
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Mar 2026

Reported quarterly figures (₹ Cr). Latest: revenue ₹474 Cr, net profit ₹8 Cr. Revenue and profit are scaled separately — hover a quarter for exact figures.

Full financials →

Others in Fertilizers & Agrochemicals this season

  • Sumitomo Chemical India Ltd (Q1 FY26)

    1,056.8 crore, up 26% YoY from Rs. Key concall takeaways from Sumitomo Chemical India Ltd's Q1 FY26 earnings call — and how it ranks against sector peers.

  • Sharda Cropchem Ltd (Q1 FY26)

    In Q1 FY 2026, revenue grew 25% year-on-year to Rs. Key concall takeaways from Sharda Cropchem Ltd's Q1 FY26 earnings call — and how it ranks against sector…

  • Paradeep Phosphates Ltd (Q1 FY26)

    Q1 volume growth was strong at 34% YoY; NPK volumes grew 48% (Pages 4, 14). Key concall takeaways from Paradeep Phosphates Ltd's Q1 FY26 earnings call — and…

  • Indogulf Cropsciences Ltd (Q1 FY26)

    Expansion of manufacturing capacity by 50-60% by fiscal end will support higher sales volumes and revenue. Key concall takeaways from Indogulf Cropsci's Q1…

🔎 Who's planning the most growth?

Companies ranked by management's own guidance — revenue, margins, capex and order book, from every earnings call in India.

See rankings →

Arthneeti Pro · Annual

Meghmani Organics Ltd and 15K+ more earnings calls,
for less than your morning chai

a day

Every earnings call, ranking and concall Q&A across all four results seasons.

Secure Razorpay payment · instant access

Frequently Asked Questions

What were Meghmani Organics Ltd Q1 FY26 results?

Meghmani Organics anticipates double-digit growth in the crop protection segment for the next 2-3 years. Meghmani Organics targets double-digit revenue growth, aiming for 15%-20% top-line growth over the next few years, particularly in crop protection.

What is Meghmani Organics Ltd share price analysis?

Meghmani Organics Ltd currently shows a neutral. The stock trades at a P/E of 25.0 with a market cap of ₹1,608 Cr. Investors should review the full earnings analysis for detailed insights.

Is Meghmani Organics Ltd planning capital expenditure?

Meghmani Organics has completed recent capex with no new capex capitalized in the latest quarter; depreciation remains stable as a result.

Keep Meghmani Organics Ltd on your radar — track it to get its next earnings analysis in your feed.

This analysis is AI-generated based on publicly available earnings data and the company's earnings call transcript. This is not investment advice. Please consult a SEBI-registered advisor before making investment decisions.